论文部分内容阅读
放疗及化疗均为恶性肿瘤的有效治疗方法.但其对患者机体免疫功能的损害已多有报导.如何在治疗期间增强患者免疫功能,提高疗效,减少复发及转移,正渐为人们重视.为此1996年10月～1997年4月,我们对100例恶性肿瘤患者进行了茶色素胶囊结合放化疗与单纯放、化疗对比研究,观察茶色素对肿瘤患者放、化疗中免疫功能的作用.1 材料与方法1.1 临床资料 选择卡氏评分60分以上,能接受放、化疗的多种恶性肿瘤患者共100例.年龄:33岁～72岁(平均50.1岁),男性61例,女性39例.其中食管癌26例、肺癌9例、肝癌2例、胃癌10例、乳腺癌28例、其他肿瘤20例,将其随机分为治疗组和对照组,每组50例,肿瘤病种及分期基本相似.1.2 治疗方法 治疗组与对照组中各放疗21例,化疗39例.放、化疗剂量及方法均按常规进行.治疗组同时加用茶色素胶囊(中外合资江西绿色制药
Radiotherapy and chemotherapy are both effective treatments for malignant tumors. However, they have reported more damage to the patient’s immune function. How to enhance the patient’s immune function during treatment, improve efficacy, reduce recurrence and metastasis, is gradually becoming more and more important for people. From October 1996 to April 1997, we conducted a comparative study of tea pigment capsule combined with radiotherapy and chemotherapy and radiotherapy and chemotherapy for 100 patients with malignant tumors to observe the role of tea pigment in the immune function of tumor patients undergoing radiotherapy and chemotherapy.1 MATERIALS AND METHODS 1.1 Clinical data A total of 100 patients with multiple malignancy who were able to undergo radiochemotherapy and chemotherapy were selected with clinical scores of 60 points. Age: 33 to 72 years (average 50.1 years), 61 males and 39 females. There were 26 cases of esophageal cancer, 9 cases of lung cancer, 2 cases of liver cancer, 10 cases of gastric cancer, 28 cases of breast cancer, and 20 cases of other tumors. They were randomly divided into treatment group and control group with 50 cases in each group. The tumor types and staging were basically the same. Similar.1.2 Treatment Methods In the treatment group and the control group, there were 21 cases of radiotherapy and 39 cases of chemotherapy. The doses and methods of radiotherapy and chemotherapy were performed routinely. The treatment group also added tea pigment capsules (Sino-foreign joint venture Jiangxi Green Pharmaceutical Co., Ltd.).